XBH-54

N/A

Report date: 2024/04/24 14:11:53

Base Information

Drug NameXBH-54
Drug Alias NameXBH54XBH-54
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsAnti-TGF-β
TargetsTransforming growth factor beta
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChance Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesChance Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A